Evidence map›Paper›PMID 25803032›Full record

ArticlePloS one2015

Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.

Dario Garcia-Carracedo, Chih-Chieh Yu, Nathan Akhavan, Stuart A Fine, Frank Schönleben, Naoki Maehara, Dillon C Karg, Chuangao Xie, Wanglong Qiu, Robert L Fine and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Recent advances in spasmolytic polypeptide expressing metaplasia research.World journal of gastrointestinal oncology · 2026
    Review
  3. Biology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Loss ofJournal of Cancer · 2019
    Article
  9. Pancreatic DCLK1Cancer letters · 2018
    Article
  10. Article
  11. Pathogenic mechanisms of pancreatitis.World journal of gastrointestinal pharmacology and therapeutics · 2017
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Dario Garcia-CarracedoThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Chih-Chieh YuThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Nathan AkhavanHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Stuart A FineHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Frank SchönlebenThe Department of Vascular Surgery in the Hospital of the University of Munich, Grosshadern, Germany.
Naoki MaeharaDepartment of Surgical Oncology and Regulation of Organ Function, Miyazaki University School of Medicine, Miyazaki, Japan.
Dillon C KargHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Chuangao XieThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Wanglong QiuThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.
Robert L FineDepartment of Medicine, Columbia University Medical Center, New York, New York, United States of America; Pancreas Center, Columbia University Medical Center, New York, New York, United States of America.
Helen E RemottiThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Department of Surgical Oncology and Regulation of Organ Function, Miyazaki University School of Medicine, Miyazaki, Japan.
Gloria H SuThe Department of Pathology, Columbia University Medical Center, New York, New York, United States of America; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America; Pancreas Center, Columbia University Medical Center, New York, New York, United States of America; Department of Otolaryngology and Head and Neck Surgery, Columbia University Medical Center, New York, New York, United States of America.
Columbia University Irving Medical Center · USLudwig-Maximilians-Universität München · DEUniversity of Miyazaki · JP

Funding

Mouse Model for Human Pancreatic Ductal AdenocarcinomaR01CA109525 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SU, GLORIA HUEI-TING · 2004 to 2015
$2.6M
DPC4 function in human pancreatic cancerK01CA095434 · NCI · JOHNS HOPKINS UNIVERSITY · PI SU, GLORIA HUEI-TING · 2002 to 2006
$707k
Mouse Model for Human Pancreatic Ductal AdenocarcinomaR56CA109525 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SU, GLORIA HUEI-TING · 2009 to 2009
$251k
NCI NIH HHS CA95434NCI NIH HHS K01 CA095434NCI NIH HHS R01 CA109525NCI NIH HHS R56 CA109525
6 · The paper itself

Abstract

aimsWhile overexpression of TGFα has been reported in human pancreatic ductal adenocarcinoma (PDAC), mice with overexpressed TGFα develop premalignant pancreatic acinar-to-ductal metaplasia (ADM) but not PDAC. TGF-β signaling pathway is pivotal to the development of PDAC and tissue fibrosis. Here we sought to investigate the interplay between TGFα and TGF-β signaling in pancreatic tumorigenesis and fibrosis, namely via Smad4 inactivation.

methodsThe MT-TGFα mouse was crossed with a new Smad4 conditional knock-out mouse (Smad4flox/flox;p48-Cre or S4) to generate Smad4flox/flox;MT-TGFα;p48-Cre (STP). After TGFα overexpression was induced with zinc sulfate water for eight months, the pancreata of the STP, MT-TGFα, and S4 mice were examined for tumor development and fibrotic responses. PanIN lesions and number of ducts were counted, and proliferation was measured by Ki67 immunohistochemistry (IHC). Qualitative analysis of fibrosis was analyzed by Trichrome Masson and Sirius Red staining, while vimentin was used for quantification. Expression analyses of fibrosis, pancreatitis, or desmoplasia associated markers (α-SMA, Shh, COX-2, Muc6, Col1a1, and Ctgf) were performed by IHC and/or qRT-PCR.

resultsOur STP mice exhibited advanced ADM, increased fibrosis, increased numbers of PanIN lesions, overexpression of chronic pancreatitis-related marker Muc6, and elevated expression of desmoplasia-associated marker Col1A1, compared to the MT-TGFα mice. The inactivation of Smad4 in the exocrine compartment was responsible for both the enhanced PanIN formation and fibrosis in the pancreas. The phenotype of the STP mice represents a transient state from ADMs to PanINs, closely mimicking the interface area seen in human chronic pancreatitis associated with PDAC.

conclusionWe have documented a novel mouse model, the STP mice, which displayed histologic presentations reminiscent to those of human chronic pancreatitis with signs of early tumorigenesis. The STP mice could be a suitable animal model for interrogating the transition of chronic pancreatitis to pancreatic cancer.

Indexed as

Gene Knockout TechniquesAcinar CellsAnimalsBiomarkersCarcinogenesisDisease ProgressionEpithelial CellsFibrosisGene ExpressionHumansMetaplasiaMiceMice, TransgenicPancreasPancreatic DiseasesPancreatic DuctsBiomarkersSmad4 ProteinTransforming Growth Factor alpha

Identifiers

PMID25803032
PMCPMC4372593
OpenAlexW2004048146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.